Minerva Neurosciences, Inc. NERV
Set alert
2.40 USD +0.05 +2.35%
As of Nov 3, 11:50 AM ET
2.37 Day range 2.48
1.96 52-week range 8.80
- YTD
- -40.30%
- 1 year
- -37.17%
- Open
- 2.37
- Prev close
- 2.35
- Mkt cap
- 115.07M
- Vol
- 102.50K
- Avg vol
- 189.88K
- EPS
- -36.12
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.37
- High
- 2.48
- Forward P/E
- -0.79
- Beta
- 0.17
- Short ratio
- 0.41
- Inst. own
- 30.47%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.33
- 200-d avg
- 2.67
- 1y target
- 5.00
Analyst view
Price target (mean) 5.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.05 | -1.05 – -1.05 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | -1.07 | -1.07 – -1.07 | -1.13 | +5.3% | 0 | 0.0% | 1 |
| Current year | -0.30 | -0.30 – -0.30 | -4.61 | +93.5% | 0 | 0.0% | 1 |
| Next year | -2.68 | -2.68 – -2.68 | -0.30 | -793.3% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 7, 2024 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| May 2, 2024 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Feb 27, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 2, 2023 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| May 16, 2023 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| May 2, 2023 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Nov 10, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Oct 17, 2022 | JMP Securities | Downgrade | Market Outperform | Market Perform |